-
Signature
-
/s/ Jeffrey E. Salvesen, Attorney-in-Fact
-
Issuer symbol
-
SCHW
-
Transactions as of
-
Jun 18, 2025
-
Transactions value $
-
-$437,545
-
Form type
-
4
-
Date filed
-
6/20/2025, 04:18 PM
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Woolway Paul V |
MD, Chief Banking Officer |
3000 SCHWAB WAY, WESTLAKE |
/s/ Jeffrey E. Salvesen, Attorney-in-Fact |
2025-06-20 |
0002031313 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
SCHW |
Common Stock |
Options Exercise |
$474K |
+10.1K |
+42.85% |
$46.81 |
33.8K |
Jun 18, 2025 |
Direct |
F1 |
| transaction |
SCHW |
Common Stock |
Sale |
-$912K |
-10.1K |
-20.55% |
$90.01 |
39.2K |
Jun 18, 2025 |
by Trust |
F2, F3 |
| holding |
SCHW |
Common Stock |
|
|
|
|
|
7.46K |
Jun 18, 2025 |
by ESPP |
|
| holding |
SCHW |
Common Stock |
|
|
|
|
|
1.14K |
Jun 18, 2025 |
by Son 1 |
|
| holding |
SCHW |
Common Stock |
|
|
|
|
|
1.14K |
Jun 18, 2025 |
by Son 2 |
|
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
SCHW |
Nonqualified Stock Option (right to buy) |
Options Exercise |
$0 |
-10.1K |
-50% |
$0.00 |
10.1K |
Jun 18, 2025 |
Common Stock |
10.1K |
$46.81 |
Direct |
F4 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: